Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 9 citations in OpenAlex.
(+)-[European journal of nuclear medicine and molecular imaging · 2021
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 3 institutions in 1 country.
Friedrich-Alexander LudwigHelmholtz-Zentrum Dresden-Rossendorf, Research Site Leipzig, Institute of Radiopharmaceutical Cancer Research, Permoserstraße 15, Leipzig 04318, Germany. f.ludwig@hzdr.de.
Steffen FischerHelmholtz-Zentrum Dresden-Rossendorf, Research Site Leipzig, Institute of Radiopharmaceutical Cancer Research, Permoserstraße 15, Leipzig 04318, Germany. s.fischer@hzdr.de.
Winnie Deuther-ConradHelmholtz-Zentrum Dresden-Rossendorf, Research Site Leipzig, Institute of Radiopharmaceutical Cancer Research, Permoserstraße 15, Leipzig 04318, Germany. w.deuther-conrad@hzdr.de.
Solveig TiepoltDepartment of Nuclear Medicine, University Hospital Leipzig, Liebigstraße 18, Leipzig 04103, Germany. solveig.tiepolt@medizin.uni-leipzig.de.
Marianne PattDepartment of Nuclear Medicine, University Hospital Leipzig, Liebigstraße 18, Leipzig 04103, Germany. marianne.patt@medizin.uni-leipzig.de.
Osama SabriDepartment of Nuclear Medicine, University Hospital Leipzig, Liebigstraße 18, Leipzig 04103, Germany. osama.sabri@medizin.uni-leipzig.de.
Peter BrustHelmholtz-Zentrum Dresden-Rossendorf, Research Site Leipzig, Institute of Radiopharmaceutical Cancer Research, Permoserstraße 15, Leipzig 04318, Germany. p.brust@hzdr.de.ORCID 0000-0001-5555-7058
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Exploring the Metabolism of (+)-[ · full record | OpenQuestion